canadian medical marijuana stocks

marijuana vape canada to Medical Cannabis Dosing Create Medical Account Tilray Medical is a leading provider of EU-GMP certified medical cannabis products in 22 countries with a comprehensive portfolio of THC and CBD products. Each medical cannabis product that Tilray offers has been selected to ensure patients can receive both the highest product quality as well as consistency when it comes to supply of their medicinal cannabis products. A little later than expected, the federal government has launched a review of the Cannabis Act. Tilray has become one of the most promising global marijuana players after its merger with Aphria and has the largest global footprint. It has products and brand recognition in both the adult-use and medical marijuana markets. Global spending on legal cannabis worldwide will hit $57 billion in a decade, according to Arcview Market Research and BDS Analytics. Driven by the legalization of recreational and medical cannabis and the increasing demand for both, legal cannabis revenue in the U.S. is projected to hit $23.4 billion by 2022. Yahoo Finance is now tracking the major players in the cannabis industry.